
Glyn Edwards appointed interim chief executive of the BioIndustry Association
pharmafile | November 24, 2011 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | BIA, Glyn Edwards
The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately.
Edwards was previously chief executive of the British biotech firm Antisoma from 1998-2011.
Prior to joining Antisoma he worked in a variety of business development roles in the biotech and healthcare industries and was also a member of the BIA Board.
Edwards has a BSc in biochemistry from Bristol University and an MSc in economics from the London Business School.
Tim Edwards, BIA chairman, said: “I am delighted that Glyn has been able to join the BIA at this time. Nigel Gaymond has left to pursue other opportunities and I thank him for his engagement with members and his contribution to the BIA over the past two years.”
Glyn Edwards, BIA chief executive, added: “I am looking forward to working with BIA members, its Board and staff to help ensure that the UK’s life sciences sector is recognised not only here in the UK but also globally.”
Related Content

What the life sciences industry wants from the next UK government
The stakes are high as the UK general election draws ever closer, and the industry …

BioIndustry Association calls for governmental support ahead of UK general election
In the run-up to the UK’s general election in June, government spending within the life …

Overcoming barriers in rare diseases
In recent months the focus on the need to develop new drugs and fund new …






